Back

Highlighting cardiovascular benefits of glucagon-like peptide-1 receptor agonists.

29 August 2020 (18:35 - 18:45)
Organised by:
Congress Presentation Part of: Discussing clinical implications of glucagon-like peptide-1 receptor agonists Pharmacotherapy Open Access ESC Congress 2020

About the speaker

Photo
Doctor Kim Connelly

St. Michael's Hospital, Toronto (Canada)

4 More presentations in this session

Presentation thumbnail
Welcome and introduction.
Professor K. Connelly (Toronto, CA)
Video
Presentation thumbnail
Evaluating cardiovascular risk reduction with glucagon-like peptide-1 receptor agonists.
Doctor M. Lehrke (Aachen, DE)
Video
Presentation thumbnail
Exploring the gap between data and clinical practice.
Assistant Professor N. Pagidipati (Durham, US)
Video
Presentation thumbnail
Panel discussion.
Doctor M. Lehrke (Aachen, DE) Professor K. Connelly (Toronto, CA) Assistant Professor N. Pagidipati (Durham, US)
Video

Access the full session

Session thumbnail
Discussing clinical implications of glucagon-like peptide-1 receptor agonists
Video

The Event

Event poster

ESC Congress 2020

29 August 2020 18:35 CET
You may be interested in
thumbnail
Congress Presentation
Effects of the glucagon like peptide-1 receptor analogue, sodium-glucose co-transporter 2 and their combination on myocardial work index and vascular function in diabetes after 3-month treatment
3 September 2019
thumbnail
Congress Session
Obesity as a cardiovascular disease: integrated management
3 April 2025
thumbnail
Webinar
Clinical trials and highlights from ACC 2024
10 April 2024
thumbnail
Congress Presentation
GLP-1 RAs reduce mortality and cardiovascular events across the spectrum of treated patients: a systematic review and meta-analysis
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources